e-learning
resources
Virtual 2020
Pre-Congress Content
Burden and predictive factors for chronic lung diseases and comorbidity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease
Z. He (Nan Ning, China), Y. Qi (Nan Ning, China)
Source:
Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Session:
Burden and predictive factors for chronic lung diseases and comorbidity
Session type:
E-poster session
Number:
2988
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. He (Nan Ning, China), Y. Qi (Nan Ning, China). Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease. 2988
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
Source: Eur Respir J 2012; 39: 1354-1360
Year: 2012
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Blood eosinophilia in chronic obstructive pulmonary disease: impact on exacerbations risk and severity
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002
Bronchial colonization and inflammatory response in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
Calorie-intake in patients hospitalized for an acute COPD exacerbation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Antibiotics in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China
Source: International Congress 2017 – COPD biomarkers
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept